Diltiazem efficacy and CYP2D6 gene polymorphism in patients with atrial fibrillation with rapid ventricular response

Diltiazem efficacy and CYP2D6 gene polymorphism in patients with atrial fibrillation with rapid ventricular response

Abstract Background Diltiazem stands out as one of the front-line drugs administered in the emergency department to achieve acute rate control in patients suffering from atrial fibrillation with rapid Ventricular Response. One of the cytochrome enzymes involved in the metabolism of diltiazem is cyto...

Full description

Bibliographic Details
Main Authors: Mehmet Uluturk, Atakan Yilmaz, Murat Seyit, Mert Ozen, Alten Oskay, Aykut Kemanci, Medine Unal, Hande Senol, Aylin Koseler, Ibrahim Turkcuer
Format: Article
Language:English
Published: SpringerOpen 2023-06-01
Series:The Egyptian Heart Journal
Subjects:
AF with RVR
CYP2D6
Diltiazem
Genetic polymorphism
Online Access:https://doi.org/10.1186/s43044-023-00375-0

Internet

https://doi.org/10.1186/s43044-023-00375-0

Similar Items